MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
66.33
-0.02 (-0.03%)
Aug 21, 2026, 4:00 PM EDT - Market closed
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $3.19 billion as of August 21, 2026. Its market cap has increased by 597.66% in one year.
Market Cap
3.19B
Enterprise Value
2.78B
1-Year Change
597.66%
Ranking
Category
Stock Price
$66.33
ChartMarket Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $3.19B, an increase of 526.78%. That is a compound annual growth rate of 157.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 3.19B | 125.56% |
| Dec 31, 2025 | 1.42B | 129.95% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| uniQure | 3.37B |
| NewAmsterdam Pharma Company | 3.32B |
| Immunome | 3.24B |
| Celldex Therapeutics | 3.19B |
| Tarsus Pharmaceuticals | 3.18B |
| Arcutis Biotherapeutics | 3.15B |
| Alumis | 3.15B |
| SELLAS Life Sciences Group | 3.11B |